Trials / Completed
CompletedNCT02468050
Study of Exercise to Manage Distress During Breast Screening
Effectiveness of Exercise Training and Self Management in the Attenuation of Anxiety and Depressive Symptoms Following Breast Biopsy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- University of Western Ontario, Canada · Academic / Other
- Sex
- Female
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The breast cancer screening and diagnostic period is associated with heightened symptoms of anxiety and depression. Physical exercise has been found to effectively decrease these symptoms in healthy and diseased populations. This study aims to determine if a pre treatment exercise intervention can minimize symptoms of anxiety and depression in women undergoing screening for breast cancer.
Detailed description
The breast cancer diagnostic process is associated with anxiety and depression. Physical exercise has emerged as an attractive non-pharmacologic approach to mitigating the psychological and physical sequelae of breast cancer and its treatments, however pre treatment interventions are not integrated into current practice. This study aims to determine the effectiveness and feasibility of a pre treatment exercise intervention in attenuating levels of anxiety and depression following breast biopsy and throughout the diagnostic period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Moderate intensity exercise training | 6 weeks of moderate intensity exercise training (50 - 75% of heart rate reserve). Sessions are facility and home based and include cardiovascular warm-up, cardiovascular training, muscular conditioning, and flexibility exercises. |
| BEHAVIORAL | Self Management of exercise | In addition to the 6 week exercise program (refer to Exercise Treatment Group), participants randomly assigned to the Self Management Group will learn strategies for the self management of exercise. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2015-06-10
- Last updated
- 2015-06-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02468050. Inclusion in this directory is not an endorsement.